Literature DB >> 24735206

Identification of transcription factors and single nucleotide polymorphisms of Lrh1 and its homologous genes in Lrh1-knockout pancreas of mice.

Maochun Tang, Li Cheng, Rongrong Jia, Lei Qiu, Hua Liu, Shu Zhou, Xiuying Ma, Guoyong Hu, Xingpeng Wang, Yan Zhao1.   

Abstract

BACKGROUND: To identify transcription factors (TFs) and single nucleotide polymorphisms (SNPs) of Lrh1 (also named Nr5a2) and its homologous genes in Lrh1-knockout pancreas of mice.
METHODS: The RNA-Seq data GSE34030 were downloaded from Gene Expression Omnibus (GEO) database, including 2 Lrh1 pancreas knockout samples and 2 wild type samples. All reads were processed through TopHat and Cufflinks package to calculate gene-expression level. Then, the differentially expressed genes (DEGs) were identified via non-parametric algorithm (NOISeq) methods in R package, of which the homology genes of Lrh1 were identified via BLASTN analysis. Furthermore, the TFs of Lrh1 and its homologous genes were selected based on TRANSFAC database. Additionally, the SNPs were analyzed via SAM tool to record the locations of mutant sites.
RESULTS: Total 15683 DEGs were identified, of which 23 was Lrh1 homology genes (3 up-regulated and 20 down-regulated). Fetoprotein TF (FTF) was the only TF of Lrh1 identified and the promoter-binding factor of FTF was CYP7A. The SNP annotations of Lrh1 homologous genes showed that 92% of the mutation sites were occurred in intron and upstream. Three SNPs of Lrh1 were located in intron, while 1819 SNPs of Phkb were located in intron and 1343 SNPs were located in the upstream region.
CONCLUSION: FTF combined with CYP7A might play an important role in Lrh1 regulated pancreas-specific transcriptional network. Furthermore, the SNPs analysis of Lrh1 and its homology genes provided the candidate mutant sites that might affect the Lrh1-related production and secretion of pancreatic fluid.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24735206      PMCID: PMC3996308          DOI: 10.1186/1471-2350-15-43

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


Background

The pancreas is an endocrine gland, producing insulin, glucagon, somatostatin, and pancreatic polypeptide, and also an exocrine gland, accounting for more than 98% of pancreatic gland and secreting pancreatic juice containing digestive enzymes [1]. These digestive enzymes help to further break down the carbohydrates, proteins and lipids in the chime and thus support the absorption and digestion of nutrition in small intestine [2]. In the past decades, many research have focused on target genes and transcription factors (TFs) involved in the exocrine pancreas-specific transcriptional networks which are required for the production and secretion of pancreatic fluid that helps out the digestive system. Currently, many exocrine pancreas-specific genes and transcription factors have been identified, which may promote the understanding of the effect of exocrine pancreas on digestive system. Liver receptor homolog-1 (Lrh1; also called Nr5a2) is a nuclear receptor of ligand-activated transcription factors in liver by binding as a monomer to DNA sequence elements with the consensus sequence 5′-Py-CAAGGPyCPu-3′ [3]. It has been suggested that Lrh1 is progressively expressed in both the endocrine and exocrine pancreas [4]. Baquié M et al. [5] have found that Lrh1 is expressed in human islets and protects β-cells against stress-induced apoptosis that may be mediated via the increased glucocorticoid production that blunts the pro-inflammatory response of islets. Meanwhile, Fayard E et al. [6] have demonstrated that both Lrh1 and CEL (encoding carboxyl ester lipase) are co-expressed and confined to the exocrine pancreas. The identification of CEL as an Lrh1-target gene indicates that Lrh1 plays an important role in enterohepatic cholesterol homeostasis associated with the absorption of cholesteryl esters and the assembly of lipoproteins by the intestine [7]. Besides, Lrh1 is a downstream target in the PDX-1 (lead to pancreas agenesis) regulatory cascade that is activated only during early stages of pancreas development and that governs pancreatic development, differentiation and function [8]. Recently, the rapid advent of next-generation sequencing has made this technology broadly available for researchers in various molecular and cellular biological fields. Holmstrom SR et al. [9] have determined the cistrome and transcriptome for the nuclear receptor LRH-1 in exocrine pancreas and revealed that Lrh1 directly induces expression of genes encoding digestive enzymes and secretory and mitochondrial proteins based on Chromatin immunoprecipitation (ChIP)-seq and RNA-seq analyses. Besides, Lrh1 cooperates with the pancreas transcription factor 1-L complex (PTF1-L) in regulation of exocrine pancreas-specific gene expression. However, many potential target genes and TFs of Lrh1 based on RNA-seq analysis have not been revealed. In the present study, we downloaded the raw RNA-seq data of Holmstrom SR et al. deposited in The National Center for Biotechnology Information (NCBI) database, which were analyzed using multiple bioinformatics tools in the purpose of finding specific TFs of Lrh1 and its homology genes. Additionally, we also annotated the SNPs of Lrh1 and its homology genes to predict their mutant sites. Our study might improve the understanding of the regulation network of Lrh1-related production and secretion of pancreatic fluid.

Methods

RNA-seq data acquisition

The RNA-seq data was downloaded from NCBI (http://www.ncbi.nlm.nih.gov/) Gene Expression Omnibus (GEO) database (GEO accession: GSE34030 [9]), including 2 Lrh1 pancreas knockout samples and 2 wild type samples. RNA preparations were subjected to the Illumina RNA-seq protocol and the platform was GPL9185.

Data pre-processing, gene expression and homology gene of Lrh1

The raw data were downloaded from SRA (Sequence Read Archive) of NCBI and then converted to fastq reads using fastq-dump program of NCBI SRA Toolkit (−q 64) (http://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?view=std). Then, these reads were processed through TopHat [10] and Cufflinks [11] package to calculate gene-expression level. All parameters were set up according to the default settings of TopHat and Cufflinks. The DEGs were identified via non-parametric algorithm (NOISeq) methods in R package [12]. The thresholds value was False Discovery Rate (FDR) < 0.001. BLASTN analysis [13,14] of the selected DEGs was used to identify the homology genes of Lrh1. Homology genes here refer to the paralogous genes which share a high degree of sequence similarity (maximum expectation value was set to e−5) with Lrh1 in mice.

Function annotation of Lrh1 homologous genes

For functional analysis of Lrh1 homologous genes, DAVID (Database for Annotation, Visualization and Integrated Discovery) [15] was performed for Gene Ontology (GO) [16] function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Transcription factor (TF) of Lrh1 homologous genes

Combined with TRANSFAC database [17], the TFs regulated the transcription of Lrh1 and its homologous genes were identified. Then, the promoter-binding factors regulated via the selected TFs were analyzed based on the website (http://www.nursa.org/molecule.cfm?molType=receptor&molId=5A2).

Screening of SNPs

The fastq reads were mapped to marker sequences using bowtie [18]. And the aligned reads were called using the SAM tool [19]. In order to minimize the risk of false-positive SNP Callings, the threshold value was that ID was “*” with quality > 50, or ID was not “*” with quality > 20. These SNPs were annotated via SnpEff [20] to categorize the effects of variants in genome sequences. The identified SNPs were searched in the dbSNP database to identify diseased SNPs or de novo discovered SNPs.

Results

Identification and homology analysis of differentially expressed genes

After data processing, at FDR < 0.001, a total of 15683 DEGs were identified, including 10994 up-regulated and 4698 down-regulated genes. BLASTN analysis of DEGs showed 23 Lrh1 homology genes. Among them, 3 were up-regulated and 20 were down-regulated (Table 1).
Table 1

homology genes of differentially expressed genes

Regulation Lrh1 homology genes
Up-regulated
Fzd5, Klrb1f, Phc1
Down-regulatedMarch8, Zfp282, Atrx, Sos2, Zfc3h1, Pofut1, Gm9079, Ykt6, Phkb, Galc, Setd1a, Fzd5, Kazn, Kcnmb1, Lamc2, Mylk4, Ache, Pbxip1, Lrh1, Phc1
homology genes of differentially expressed genes

Function and pathway annotation of Lrh1 homologous genes

To determine the function of Lrh1 homologous genes in pancreas, GO enrichment analysis and KEGG pathway enrichment analysis were used to analyze the up- and down-regulated Lrh1 homologous genes. For function and pathway annotation, DEGs were enriched into hexose metabolic process and monosaccharide metabolic process, which were involved into glycometabolism (Figure 1). Meanwhile, KEGG pathway enrichment analysis identified insulin signaling pathway, indicating that the disorders of glycometabolism might be resulted from insulin resistance and/or insulin secretion (Figure 2). PHKB, an Lrh1 homologous gene, participated in GO terms (hexose metabolic process and monosaccharide metabolic process) and KEGG pathway (insulin signaling pathway), was identified.
Figure 1

GO functional annotation of and its homology genes. GO terms included Molecular Function (MF) GO-terms (A), Biological Process (BP) GO-terms (B) and Cellular Component (CC) GO-terms (C).

Figure 2

KEGG pathway annotations of and its homology genes.

GO functional annotation of and its homology genes. GO terms included Molecular Function (MF) GO-terms (A), Biological Process (BP) GO-terms (B) and Cellular Component (CC) GO-terms (C). KEGG pathway annotations of and its homology genes.

Potential TFs of Lrh1 homologous genes

Fetoprotein transcription factor (FTF) (ID: T04754) of Lrh1 was the only TF identified based on TRANSFAC database. Meanwhile, the promoter-binding factor of Lrh1 was CYP7A (Cholesterol 7α-hydroxylase).

SNPs of Lrh1 homologous genes

The annotation of SNPs of Lrh1 homologous genes showed that the majority of SNPs were located in intron and upstream, accounting for nearly 92% of all SNPs (Tables 2 and 3). Three SNPs of Lrh1 were distributed in intron. Meanwhile, total 1819 SNPs of Phkb were located in the intron and 1343 SNPs were located in the upstream region of Phkb.
Table 2

The number of different type of SNPs of and its homology genes

TypeNumberProportion
Downstream
581
0.052234
Intron
8251
0.741796
Non-synonymous-coding
122
0.010968
Splice-site-donor
2
0.00018
Start-gained
4
0.00036
Stop-gained
5
0.00045
Synonymous-coding
97
0.008721
Upstream
1975
0.17756
UTR-3-prime
79
0.007102
UTR-5-prime70.000629
Table 3

The annotation of SNPs of and its homology genes

Gene nameChromoNumberPosition
Zfc3h1
10
4
115385510
Galc
12
36
98232394-98232429
Mylk4
13
13
32711300-32711312
Fzd5
1
22
64737712-64737722
Lrh1
1
6
136849713-136870578
Lamc2
1
923
153145967-153191429
Pofut1
2
188
153239719-153275253
Ache
5
19
137288432-137288449
Zfp282
6
1016
47876551-47913485
8-Mar
6
4231
116342541-116360897
Setd1a
7
1834
127778726-127802950
Phkb
8
3197
85837045-86008353
AtrxX7105863283-105906922
The number of different type of SNPs of and its homology genes The annotation of SNPs of and its homology genes

Discussion

In the present study, combined with RNA-seq data of Lrh1-knockout pancreas samples, FTF was the only TF of Lrh1 identified based on TRANSFAC database and may regulate cholesterol catabolism into bile acids by activation of the promoter-binding factor CYP7A. Many literatures have elucidated the function of Lrh1/Nr5a2/FTF/CYP7A via experimental studies [21-25]. FTF is highly expressed in the liver and intestine and is implicated in the regulation of cholesterol, bile acid and steroid hormone homeostasis [26]. Nearly 50% of the body cholesterol is catabolized to bile acids via bile acid biosynthetic pathway, of which cholic acid (hydroxylated at position 12) and chenodeoxycholic acid are the major primary bile acids and play an important role in cholesterol homeostasis [19]. Chenodeoxycholic acid can repress FTF expression and is a more potent suppressor of HMG-CoA reductase and cholesterol 7α-hydroxylase/CYP7A1 (7α-hydroxylase) than cholic acid [27]. It has been proposed that Lrh1, also known as CYP7A promoter-binding factor, LRH1, or FTF, is required for the transcription of the 7α-hydroxylase gene [19,28]. The small heterodimer partner 1 (SHP) of the nuclear bile acid receptor, FXR (farnesoid X receptor) can dimerize with FTF and diminish its activity on the 7α-hydroxylase promoter [29]. Although Lrh1 has been demonstrated the function in feedback regulation of CYP7A1 expression as part of the FXR-SHP-LRH-1 cascade, in which bile acids can inhibit their own synthesis, the mechanisms have not been well understood. Out C et al. [25] have suggested that CYP7A1 expression is increased rather than decreased under chow-fed conditions in Lrh1-knockdown mice that is coincided with a significant reduction in expression of intestinal Fgf15, a suppressor of CYP7A1. Besides, Noshiro M et al. [30] have suggested that the circadian rhythm of CYP7A is regulated by multiple transcription factors, including DBP, REV-ERBα/β, LXRα, HNF4α DEC2, E4BP4, and PPARα. Hepatocyte nuclear factor 4α (HNF4α) and FTF are two major TFs driving CYP7A1 promoter activity in lipid homeostasis. Bochkis IM et al. [31] have shown that prospero-related homeobox (Prox1) directly interacts with both HNF4α and FTF and potently co-represses CYP7A1 transcription. In the present study, we annotated the SNPs of Lrh1 and its homologous genes, showing that the majority was located in intron and upstream. Quiles Romagosa MÁ [32] has reported that a functional SNP located in Lrh1 promoter is related to Body Mass Index (BMI) and these SNPs might play important roles in the obese phenotype. However, previous researches mostly focused on SNPs associated with pancreatic cancer cell growth and proliferation. For example, a previous genome-wide association study has identified five SNPs on 1q32.1 associated with pancreatic cancer that mapped to Lrh1 gene and its up-stream regulatory region [33].

Conclusions

In conclusion, FTF combined with CYP7A might play an important role in Lrh1 regulated pancreas-specific transcriptional network. Furthermore, the SNPs analysis of Lrh1 and its homology genes provided the candidate mutant sites that might affect the Lrh1-related production and secretion of pancreatic fluid. These common susceptibility loci for Lrh1 and its homologous genes needed follow-up studies.

Highlights

1. Total 15683 DEGs were identified, of which 23 was Lrh1 homology genes (3 up-regulated and 20 down-regulated). 2. Fetoprotein TF was the only TF of Lrh1 identified based on TRANSFAC database and the promoter-binding factor of fetoprotein TF was CYP7A. 3. The SNP annotations of Lrh1 homologous genes showed that 92% of mutation sites were occurred in intron and upstream. Three SNPs of Lrh1 were located in intron, while 1819 SNPs of Phkb were located in intron and 1343 SNPs were located in upstream region.

Competing interest

The authors declare that they have no competing interests.

Authors’ contributions

MT, XM and CL participated in the design of this study, and they both performed the statistical analysis. RJ, GYH and YZ carried out the study, together with LQ, collected important background information, and drafted the manuscript. HL, XPW and ZS conceived of this study, and participated in the design and helped to draft the manuscript. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2350/15/43/prepub
  31 in total

Review 1.  Autoregulation of cholesterol synthesis: physiologic and pathophysiologic consequences.

Authors:  Robert J Fakheri; Norman B Javitt
Journal:  Steroids       Date:  2010-10-15       Impact factor: 2.668

2.  The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3beta in the developing murine liver, intestine and pancreas.

Authors:  F M Rausa; L Galarneau; L Bélanger; R H Costa
Journal:  Mech Dev       Date:  1999-12       Impact factor: 1.882

3.  The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis.

Authors:  Mathurin Baquié; Luc St-Onge; Julie Kerr-Conte; Nadia Cobo-Vuilleumier; Petra I Lorenzo; Carmen M Jimenez Moreno; Christopher R Cederroth; Serge Nef; Sophie Borot; Domenico Bosco; Haiyan Wang; Piero Marchetti; Francois Pattou; Claes B Wollheim; Benoit R Gauthier
Journal:  Hum Mol Genet       Date:  2011-05-02       Impact factor: 6.150

4.  α(1)-Fetoprotein Transcription Factor (FTF)/Liver Receptor Homolog-1 (LRH-1) Is an Essential Lipogenic Regulator.

Authors:  Zhumei Xu; Lingli Ouyang; Antonio Del Castillo-Olivares; William M Pandak; Gregorio Gil
Journal:  Biochim Biophys Acta       Date:  2009-12-28

Review 5.  Emerging roles for LXRs and LRH-1 in female reproduction.

Authors:  Kevin Mouzat; Silvère Baron; Geoffroy Marceau; Françoise Caira; Vincent Sapin; David H Volle; Serge Lumbroso; Jean-Marc Lobaccaro
Journal:  Mol Cell Endocrinol       Date:  2012-06-28       Impact factor: 4.102

6.  The role of alpha1-fetoprotein transcription factor/LRH-1 in bile acid biosynthesis: a known nuclear receptor activator that can act as a suppressor of bile acid biosynthesis.

Authors:  Antonio del Castillo-Olivares; José A Campos; William M Pandak; Gregorio Gil
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

7.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Authors:  Gloria M Petersen; Laufey Amundadottir; Charles S Fuchs; Peter Kraft; Rachael Z Stolzenberg-Solomon; Kevin B Jacobs; Alan A Arslan; H Bas Bueno-de-Mesquita; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Harvey A Risch; Wei Zheng; Demetrius Albanes; William R Bamlet; Christine D Berg; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Manal Hassan; Barbara Howard; David J Hunter; Amy Hutchinson; Mazda Jenab; Rudolf Kaaks; Charles Kooperberg; Vittorio Krogh; Robert C Kurtz; Shannon M Lynch; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Hemang Parikh; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Laudina Rodriguez; Daniela Seminara; Xiao-Ou Shu; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Zhaoming Wang; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Joseph F Fraumeni; Robert N Hoover; Patricia Hartge; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

8.  Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2.

Authors:  Irina M Bochkis; Jonathan Schug; Diana Z Ye; Svitlana Kurinna; Sabrina A Stratton; Michelle C Barton; Klaus H Kaestner
Journal:  PLoS Genet       Date:  2012-06-21       Impact factor: 5.917

9.  TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes.

Authors:  V Matys; O V Kel-Margoulis; E Fricke; I Liebich; S Land; A Barre-Dirrie; I Reuter; D Chekmenev; M Krull; K Hornischer; N Voss; P Stegmaier; B Lewicki-Potapov; H Saxel; A E Kel; E Wingender
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  1 in total

1.  Genome Editing As an Approach to the Study of in Vivo Transcription Reprogramming.

Authors:  Y Y Silaeva; V A Kalmykov; E A Varlamova; E N Korshunov; D S Korshunova; M V Kubekina; A A Shtil; I B Roninson; A V Deykin
Journal:  Dokl Biochem Biophys       Date:  2020-04-27       Impact factor: 0.788

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.